| Stage | AGL | % of rev | DVA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.5B | 100.00% | $3.6B | 100.00% | DVA ×2.35 |
| Gross profit | $1.5B | 100.00% | $1.1B | 31.50% | AGL +68.5pp |
| Operating income | $24M | 1.59% | $499M | 13.95% | DVA +12.4pp |
| Pre-tax income | $39M | 2.56% | $359M | 10.02% | DVA +7.5pp |
| Net income | $35M | 2.30% | $269M | 7.53% | DVA +5.2pp |
| Stage | AGL | DVA | Gap · A − B |
|---|---|---|---|
| Revenue | $1.5B100.00% | $3.6B100.00% | DVA ×2.35 |
| Gross profit | 100.00%$1.5B | 31.50%$1.1B | AGL +68.5pp |
| Operating income | 1.59%$24M | 13.95%$499M | DVA +12.4pp |
| Pre-tax income | 2.56%$39M | 10.02%$359M | DVA +7.5pp |
| Net income |
| 2.30%$35M |
| 7.53%$269M |
| DVA +5.2pp |
None
No disclosed counterparties: AGL.